SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-020073
Filing Date
2023-05-10
Accepted
2023-05-10 07:11:19
Documents
13
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K coya-20230510.htm   iXBRL 8-K 56609
2 EX-99.1 coya-ex99_1.htm EX-99 217697
  Complete submission text file 0000950170-23-020073.txt   409828

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT coya-20230510_lab.xml EX-101.LAB 14018
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT coya-20230510_pre.xml EX-101.PRE 10303
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT coya-20230510.xsd EX-101.SCH 2493
7 EXTRACTED XBRL INSTANCE DOCUMENT coya-20230510_htm.xml XML 4929
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 23904310
SIC: 2834 Pharmaceutical Preparations